MSTN and obesity due to melanocortin 4 receptor deficiency: Thus, 16 weeks of n-3 supplementation and of RT alone, but not in combination, decreased myostatin circulating levels in postmenopausal women with overweight/obesity in the absence of changes in skeletal muscle mass.